Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation

American Journal of Hematology

Volumn 76, Issue 2, 2004, Pages 156-162

  Belford, Amy ^a   Myles, Otha ^a   Magill, Alan ^a,b   Wang, James ^c   Myhand, Rick C ^a   Waselenko, Jamie K ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Autologous stem cell transplantation; Encephalitis; Human herpesvirus 6; Melphalan; Stroke; Thrombotic microangiopathy; TTP

Indexed keywords

ACICLOVIR; CASPOFUNGIN; COTRIMOXAZOLE; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; MELPHALAN; METHYLPREDNISOLONE; VANCOMYCIN; VINCRISTINE; VIRUS DNA;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; DRUG MEGADOSE; FEMALE; HERPES; HUMAN; HUMAN HERPESVIRUS 6; INFECTION; INFECTION PREVENTION; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMAPHERESIS; PRIORITY JOURNAL; STROKE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS REACTIVATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIVIRAL AGENTS; CEREBROVASCULAR ACCIDENT; COMBINED MODALITY THERAPY; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; ROSEOLOVIRUS INFECTIONS; STEM CELL TRANSPLANTATION; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 2542612293     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20068     Document Type: Article

References (42)

1. Raybon KB, Snyder MJ, Halvorson RD. Hemolytic uremic syndrome after autologous BMT without TBI. Bone Marrow Transplant 1996;17:897-898.
2. Carlson K, Smedmyr B, Hagberg H, et al. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) ± TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993;11:205-208.
3. Van der Lelie H, Baars JW, Rodenhuis S, et al. Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support. Cancer 1995;76:2338-2342.
4. Sarode R, McFarland JG, Flomenberg N, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1995;16:271-275.
5. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-1050.
6. Cone RW, Huang M-L, Corey L, et al. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999;179:311-318.
7. Yoshikawa T, Asano Y, Ihira M, et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002;185:847-853.
8. Yoshikawa T, Ihira M, Ohashi M, et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;28:77-81
9. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-3310.
10. Johnston RE, Geretti AM, Prentice HG et al. HHV-6-related secondary graft failure following allogeneic bone marrow transplantation. Br J Haematol 1999;105:1041-1043.
11. Rosenfeld CS, Rybka WB, Weinbaum D, et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995;23:626-629.
12. Matsuda Y, Hara J, Miyoshi H, et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant 1999;24:919-923.
13. Goncalves AV, Ginani VC, Pereira C, et al. HHV-6 after bone marrow transplantation. Blood 2001;98:357b.
14. Lusso P, Gallo RC. Human herpesvirus 6. Baillieres Clin Haematol 1995;8:201-223.
15. Briggs M, Fox J, Tedder RS. Age prevalence of antibody to human herpesvirus 6. Lancet 1989;1(8593):1058-1059.
16. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989;27:651-653.
17. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171(2):273-280.
18. Wang FZ, Linde A, Hagglund H, et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999;28:5628.
19. Kidd IM, Clark DA, Bremner JA, et al. A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. J Virol Methods 1998;70:29-36.
20. Takasuka H, Wakae T, Mori A, et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Blood 2003;31:475-479.
21. Hasegawa D, Sano K, Kosaka Y, et al. Infantile T cell acute lymphoblastic leukemia complicated by thrombotic microangiopathy and human herpes virus 6 infection after allogeneic peripheral blood stem cell transplantation using CD34-positive cells. Rinsho Ketsueki 1999;40(7):574-580.
22. Battegay EJ, Mihatsch MJ, Mazzucchelli L, et al. Cytomegalovirus and kidney. Clin Nephrol 1988;30(5):239-247.
23. Gruber O, Wittig L, Wiggins CJ, von Cramon DY. Thrombotic thrombocytopenic purpura: MRI demonstration of persistent small cerebral infarcts after clinical recovery. Neuroradiology 2000;42:616-618.
24. Urushitani M, Seriu N, Udaka F, et al. MRI demonstration of a reversible lesion in cerebral deep white matter in thrombotic thrombocytopenic purpura. Neuroradiology 1996;38:137-138.
25. Webb DW, Bjornson BH, Sargent MA, et al. Basal ganglia infarction associated with HHV-6 infection. Arch Dis Child 1997;76:362-364.
26. Gilden DH, Lipton HL, Wolf JS, et al. Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med 2002;347(19):1500-1503.
27. Ishiguro N, Yamada S, Takahashi T, et al. Meningoencephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990;79:987-989.
28. Studahl M, Hagberg L, Rekabdar E, Bergstrom T. Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between α-, β, and γ-herpesviruses. Scand J Infect Dis 2000;32(3):237-248.
29. Wang FZ, Linde A, Hagglund H, et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999;28(3):562-568.
30. Ljungman P, Wang F-Z, Linde A, et al. Human herpesvirus type 6 (HHV-6) encephalitis in allogeneic BMT recipients. Blood 1997;90(Suppl 1):543a.
31. Zerr DM, Gupta D, Huang M-L, et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:309-317.
32. MacLean HJ, Douen AG. Severe amnesia associated with human herpesvirus 6 encephalitis after bone marrow transplantation. Transplantation 2000;73:1086-1089.
33. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-1360.
34. Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 in transplant recipients. Transplantation 2000;69:2474-2479.
35. Sashihara J, Tanaka-Taya K, Tanaka S, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002;100:2005-2011.
36. Humar A, Malkan G, Moussa G, et al. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000;181:1450-1453.
37. Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000;69:2566-2573.
38. Lawrence GL, Chee M, Craxton MA, et al. Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol 1990;64:287-299.
39. Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treat tent of human herpesvirus-6 in allogeneic stem cell transplanta ion. Bone Marrow Transplant 2002;29:595-598.
40. Rapaport D, Engelhrd D, Tagger G, et al. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002;4:10-16.
41. Yoshida H, Matsunaga K, Ueda T, et al. Human herpesvirus 6 meningoencephalitis successfully treated with ganciclovir in a patient who underwent allogeneic bone marrow transplantation from an HLA-identical sibling. Int J Hematol 2002;75:421-425.
42. Streicher HZ, Hung CL, Ablashi DV, et al. In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods 1988;21(14):301-304.